(Image: Getty/Martin Barraud)

July roundup: Regulators experience a busy month

By Ben Hargreaves

July has seen a number of actions taken by regulators to manage the supply of medicine, including a crackdown on CBD manufacturers and repackers of opioid medication.

(Image: Getty/Nedomacki)

FDA finds cGMP documents in Strides’ scrap yard

By Ben Hargreaves

In a warning letter, the US FDA details how its inspectors discovered cGMP document awaiting shredding and records discarded in a 55-gallon drum at Strides’ facility.

(Image: Getty/ugurhan)

Mylan expands valsartan recall in US

By Flora Southey

Mylan has requested all lots of valsartan, as well as combination amlodipine/valsartan, and valsartan/ hydrochlorothiazide tablets, be returned in the US.